• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Qualifacts Acquires MethodOne to Add Controlled-Medication Dispensing to Behavioral Health EHR

by Fred Pennic 04/07/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Qualifacts Acquires MethodOne to Add Controlled-Medication Dispensing to Behavioral Health EHR

What You Should Know

  • The Acquisition: Qualifacts, a major behavioral health Electronic Health Record (EHR) provider, has acquired MethodOne by Computalogic. Financial terms were not disclosed.
  • The Target (MethodOne): MethodOne provides comprehensive controlled-medication dispensing software that is purpose-built for Opioid Treatment Programs (OTPs) and Substance Use Disorder (SUD) providers.

Following the Billing Workflows

According to Qualifacts, treatment agencies are actively shifting away from standard office-based opioid treatment (OBOT) models and transitioning into full-fledged Opioid Treatment Programs (OTPs). Why? Because the billing workflows for OTPs—which collectively treat over half a billion patients annually, heavily skewing toward Medicaid—are simpler and more structured.

However, taking advantage of those OTP billing structures requires software that can flawlessly track medication inventory, verify dispensing limits, and link those actions directly to a billable clinical encounter. MethodOne brings exactly that specialized functionality in-house for Qualifacts.

“Large SUD and mental health organizations require an integrated MAT [Medication-Assisted Treatment] and MOUD [Medications for Opioid Use Disorder] solution to operate effectively, and until now, that has meant cobbling together multiple systems,” said Josh Schoeller, CEO of Qualifacts. “Bringing MethodOne into the Qualifacts family means our customers get a more complete behavioral healthcare EHR platform.”

Consolidation for Compliance

OTPs operate under extreme regulatory scrutiny from overlapping agencies, including the DEA, SAMHSA, and state regulators. As the opioid crisis continues to demand scaled, efficient treatment options, behavioral health providers cannot afford to waste time managing clunky API bridges between mismatched vendors. Qualifacts’ acquisition of MethodOne signals that the era of the fragmented addiction treatment tech stack is coming to an end, giving way to unified platforms that protect both the patient and the provider’s license.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Optum Partners with Anthropic to Deploy Claude Across Healthcare Claims and Revenue Workflows

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Rock Health H1 2026 Digital Health Funding Recap: Startups Hit $7.4B in Venture Rebound

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |